Increased duration and similar outcomes of V-V ECLS in patients with COVID-19 ARDS compared to non-COVID ARDS: Single center experienceObservational Study Published on 2023-04-012023-07-10 Journal: Artificial organs [Category] COVID19(2023년), [키워드] acute respiratory distress syndrome Coronavirus disease-19 extracorporeal life support extracorporeal membrane oxygenation. [DOI] 10.1111/aor.14463 PMC 바로가기 [Article Type] Observational Study
Clinical, laboratory, and chest radiographic characteristics of COVID-19 associated severe pediatric pneumonia. A retrospective studyArticle Published on 2022-12-012023-07-11 Journal: Saudi medical journal [Category] COVID19(2023년), [키워드] children Coronavirus disease-19 COVID-19 pneumonia. SARS-CoV-2 [DOI] 10.15537/smj.2022.43.12.20220420 PMC 바로가기
Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylationArticle Published on 2022-11-082022-11-15 Journal: Vaccine [Category] SARS, 진단, [키워드] 293 cells 293F cell acute respiratory syndrome addition binding caused Cell changed characterization convalescent sera coronavirus Coronavirus disease-19 COVID-19 Critical discrepancy effective Efficacy elicited exhibited expression globe glycosylated glycosylation glycosylation pattern homogeneity host cells IgG immunization immunogenicity insect cell mammalian cells mice Neutralizing antibody response neutralizing antibody titre pandemic Protein Proteins provide reactivity Receptor binding regimen robust S protein S-2P SARS-CoV-2 SARS-CoV-2 spike protein spike Spike. the S protein thermal stability Vaccine Vaccine design Variation virus virus entry while [DOI] 10.1016/j.vaccine.2022.09.057 PMC 바로가기
Immunogenicity of Third-dose BNT162b2 mRNA Vaccine Following Two Doses of ChAdOx1 in Health Care Workers: A Prospective Longitudinal StudyArticle Published on 2022-11-012022-11-16 Journal: Annals of laboratory medicine [Category] SARS, 변종, [키워드] acute respiratory syndrome analyzed anti-S antibody BNT162b2 BNT162b2 mRNA ChAdOx1 collected Concentration coronavirus Coronavirus disease-19 COVID-19 delta variant demonstrated dose doses Effectiveness Efficacy eight healthcare worker help immunogenicity longitudinal NAbs Neutralizing neutralizing antibody occurred omicron outbreak pandemic predicted produced Prospective PROTECT reached regimen risk second dose study period the vaccine Three-dose vaccination. university hospital vaccination vaccination rate variant variants of concern Wuhan-Hu-1 [DOI] 10.3343/alm.2022.42.6.688 PMC 바로가기
Association of Interleukin-17F Polymorphism and Mortality Predictors with the Risk of COVID-19Article Published on 2022-10-272022-11-15 Journal: International journal of clinical practice [Category] 변종, 진단, [키워드] age allele Analysis association AUC case-control study CD4 cells Characteristics control subject controls Coronavirus disease-19 COVID-19 COVID-19 infection COVID-19 mortality COVID-19 patient COVID-19 patients cutoff point D-dimer death determine enzyme-linked immunosorbent exhibiting expression Genotype genotyping healthy higher odd hypertension IL-17 immunological injuries in-hospital mortality independent predictor investigated Laboratory no significant difference non-survivor outcome participant polymorphism predictor proinflammatory risk of COVID-19 ROC Curve subset suggested survivor susceptibility T lymphocytes tested variant WBC White blood cell with COVID-19 [DOI] 10.1155/2022/4761631 PMC 바로가기
Early suppression of antiviral host response and protocadherins by SARS-CoV-2 Spike protein in THP-1-derived macrophage-like cellsArticle Published on 2022-10-202022-11-15 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 치료제, [키워드] acute respiratory syndrome Alpha Antiviral approved Cell cells cellular cellular response change coronavirus Coronavirus disease-19 COVID-19 cytokine differentially expressed downregulation Effect effort expressing expression highlight homeostasis host cells host response humoral immune responses induce Infection information interferon intrinsic involved medium pandemic pathogenic PROTECT Protein reflected Result S protein SARS-CoV-2 spike Spike protein the S protein transcriptomic transcriptomics transcriptomics. type I Vaccination strategies Vaccine variety while [DOI] 10.3389/fimmu.2022.999233 PMC 바로가기
Theoretical investigation on the interactions of microplastics with a SARS-CoV-2 RNA fragment and their potential impacts on viral transport and exposureSARS-CoV-2 RNA 단편과 미세 플라스틱의 상호 작용 및 바이러스 수송 및 노출에 대한 잠재적 영향에 대한 이론적 조사Article Published on 2022-10-102022-09-11 Journal: The Science of the total environment [Category] COVID19(2023년), SARS, 유전자 메커니즘, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Affect affinity Behavior Behavior and fate cause condition coronavirus coronavirus disease Coronavirus disease-19 COVID-19 determine electrostatic environmental conditions Environmental pollution Evidence exposure to facilitate FIVE greater HBV hepatitis B Hepatitis B virus Human hydrophobic Impact independent independent of inherent Interaction involved Lungs mechanism media Microplastic pollution microplastics molecular molecular dynamic simulations molecular interaction molecular volume Nucleic acid material pandemic pandemic spread parameter polar risk RNA RNA fragment SARS-CoV-1 SARS-CoV-2 SARS-CoV-2 RNA SARS-CoV-2 transmission SARS-CoV-2. severe acute respiratory syndrome Coronavirus Spread strong interaction surface area temperature the SARS-CoV-2 Transport vacuum virus water [DOI] 10.1016/j.scitotenv.2022.156812 PMC 바로가기 [Article Type] Article
Computational and experimental insights on the interaction of artemisinin, dihydroartemisinin and chloroquine with SARS-CoV-2 spike protein receptor-binding domain (RBD)Article Published on 2022-10-012022-11-15 Journal: Natural Product Research [Category] COVID19(2023년), SARS, 치료제, [키워드] ACE2 acute respiratory syndrome angiotensin-converting enzyme 2 antimalarial Antiviral agents Artemisinin bind bio-layer interferometry Chloroquine Complexes Compound computational tool Coronavirus disease-19 Coronavirus-2 COVID-19 demonstrated derivative docking study domain drug candidate host cell in vitro Interaction interfere Invasion investigated mechanism mechanisms metabolite molecular molecular dynamics predicted Protein RBD SARS-CoV-2 SARS-CoV-2 spike protein small molecule Spike protein spike protein. stability treat [DOI] 10.1080/14786419.2021.1925894 PMC 바로가기
Antibody response three months after SARS-CoV-2 infectionSARS-CoV-2 감염 3개월 후 항체 반응Article Published on 2022-10-012022-09-12 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] acute respiratory syndrome anti-SARS-CoV-2 antibody antibody level Antigen applied coated with collected coronavirus Coronavirus disease-19 cough COVID-19 COVID-19 infection determine ELISA fatigue Hospitalized IgG immune immune responses Immunoglobulin individual individuals Infection Insomnia joint loss of taste Pain pandemic positive Postinfection Prevent problem public health Reinfection Research SARS Coronavirus SARS-CoV-2 SARS-CoV-2 antibodies SARS-COV-2 infection serum antibody serum sample state Symptom Tarsus tested those with comorbidities threshold virus virus classification. weakness [DOI] 10.1002/jmv.27909 PMC 바로가기 [Article Type] Article
Seroconversion and outcomes after initial and booster COVID-19 vaccination in adults with hematologic malignanciesArticle Published on 2022-09-152022-11-15 Journal: Cancer [Category] 진단, [키워드] active malignancy analyzed antibodies antibody association Asymptomatic booster booster dose booster vaccination Cancer coronavirus coronavirus disease Coronavirus disease-19 Course COVID-19 COVID-19 infection COVID-19 vaccination COVID-19-related death death decrease detectable diagnosed died effective eliminated Hematologic malignancy high-risk population humoral Humoral immunity immunization incidence of COVID-19 Infection initial lack less lowest lymphoma Lymphoma. malignancy monoclonal antibody occurred outcome outcomes Patient postvaccination promote Prophylactic proportion reduced response to vaccination revaccination risk risk of COVID-19 Seroconversion seroconversion rate Serologic response seronegative suggested the patient therapy treated Treatment undetectable vaccination Vaccine [DOI] 10.1002/cncr.34354 PMC 바로가기